BioPQQ®
One of the few widely available compounds with preclinical evidence for stimulating mitochondrial biogenesis — supporting new mitochondria via PGC-1α activation while cycling through 20,000 redox reactions per molecule (in vitro).
Primacy Research
What BioPQQ® Does For You
Mitochondrial Biogenesis
BioPQQ® is among the few widely available supplements with clinical evidence for stimulating the creation of new mitochondria via PGC-1α → NRF-1 → TFAM activation — not just protecting existing ones.
20,000-Cycle Antioxidant
PQQ cycles through ~20,000 redox reactions per molecule vs. ~4 for glutathione — roughly 5,000x more catalytically efficient, providing sustained defense at the mitochondrial electron transport chain.
45% CRP Reduction in 72 Hours
Harris et al. (2013) demonstrated BioPQQ® reduced C-reactive protein by ~45% within just 72 hours (open-label, n=10, no control group) — a notable anti-inflammatory signal, though from a very small uncontrolled study.
NGF Stimulation for Cholinergic Neurons
PQQ stimulates nerve growth factor (NGF) synthesis in astrocytes — supporting the survival and maintenance of cholinergic neurons that are critical for memory and attention.
Improved Cognitive Function & Sleep
Clinical trials show BioPQQ® improves attention, processing speed, and prefrontal blood flow, while also enhancing sleep quality — addressing both the performance and recovery sides of brain health.
Your Mitochondrial Fleet Is Shrinking
The brain runs on mitochondrial ATP. A single cortical neuron contains 2,000+ mitochondria — more than any other cell type. With age, mitochondrial biogenesis slows, efficiency drops, and ROS production increases. By 70, mitochondrial ATP capacity may decline 40–50%. Most mitochondrial supplements protect or fuel existing mitochondria. PQQ is one of the few supplement compounds with published evidence for supporting mitochondrial biogenesis.
Biogenesis Shutdown
PGC-1α — the master regulator of mitochondrial creation — declines with age. Fewer new mitochondria are born while damaged ones accumulate. The fleet shrinks and degrades simultaneously.
The Neural Energy Crisis
Neurons cannot downshift to glycolysis like muscle cells. When mitochondrial output drops below threshold, synaptic signaling fails before the neuron dies — manifesting as brain fog, slow processing, and impaired working memory.
The ROS Vicious Cycle
Damaged mitochondria generate more reactive oxygen species, which damage mitochondrial DNA (unprotected by histones), which further impairs the mitochondria, which generate more ROS. Without new mitochondria to replace damaged ones, this cycle accelerates.
How BioPQQ® Works
PQQ (pyrroloquinoline quinone) is a redox cofactor found in soil, fermented foods, and human breast milk. It is among the few compounds widely available as a supplement with demonstrated ability to activate the mitochondrial biogenesis cascade — supporting the growth of new mitochondria.
PGC-1α Activation — The Biogenesis Master Regulator
PQQ phosphorylates CREB, which upregulates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha) — the transcription coactivator that controls mitochondrial biogenesis. PGC-1α activates NRF-1/NRF-2 transcription factors, which drive TFAM (mitochondrial transcription factor A) into the mitochondrial matrix to replicate mtDNA and build new electron transport chains.
20,000-Cycle Redox Capacity
In vitro, PQQ cycles between oxidized (PQQ) and reduced (PQQH₂) forms approximately 20,000 times before degradation — compared to ~4 cycles for glutathione and ~800 for vitamin C. This redox cycling comparison in controlled conditions makes PQQ roughly 5,000x more catalytically efficient per molecule in vitro, though this is not a direct measure of in-vivo antioxidant efficacy.
NGF Stimulation
Preclinical evidence suggests PQQ stimulates nerve growth factor (NGF) synthesis in astrocytes. NGF supports survival and maintenance of cholinergic neurons in the basal forebrain. No human evidence links PQQ supplementation to neurodegenerative disease prevention. This product is not intended to prevent or treat any disease. This provides a neurotrophic complement to the BDNF upregulation from CognatiQ® and Sabroxy®.
Anti-Inflammatory Action
PQQ suppresses NF-κB signaling, reducing C-reactive protein by ~45% (open-label, n=10, no control group) and IL-6 significantly within just 72 hours at 20 mg/day. Neuroinflammation is a primary accelerant of mitochondrial dysfunction — PQQ may help break this feedback loop.
What the Research Shows
BioPQQ® is supported by clinical trials examining cognition, sleep quality, and inflammatory biomarkers.
Itoh et al. (2016). Functional Foods in Health and Disease, 58(3):197-201. BioPQQ 20 mg/day. Improved attention, processing speed, and prefrontal blood flow.
Nakano et al. (2012). Functional Foods in Health and Disease, 2(8):307-324. BioPQQ 20 mg/day, 8-week crossover.
Harris et al. (2013). Journal of Nutritional Biochemistry, 24(12):2076-2084. BioPQQ 20 mg/day. CRP reduced ~45%, IL-6 significantly reduced in just 72 hours.
Your Daily Dose in APEX
Why this dose works: The primary clinical trials (Itoh 2016, Nakano 2012, Harris 2013) used 20 mg/day. APEX delivers 10 mg — half the 20 mg dose used in cited clinical trials. The lower dose is based on the rationale that PQQ activates PGC-1α at low concentrations in cell studies, though clinical equivalence at 10 mg has not been directly demonstrated. Within the comprehensive mitochondrial stack (alongside ALCAR, Na-R-ALA, Di-Mag Malate, and ErgoX), this dose is intended to provide biogenesis activation while the synergistic partners address complementary metabolic nodes.
How BioPQQ® Connects Across the System
BioPQQ® is the upstream driver of the mitochondrial lifecycle — creating the new mitochondria that the rest of the stack fuels, runs, and protects across both APEX and RESET.
The Complete Mitochondrial Lifecycle
BioPQQ® creates new mitochondria (PGC-1α). ALCAR delivers the fuel (carnitine shuttle). Di-Mag Malate provides the Krebs cycle substrate and ATP synthase cofactor. Na-R-ALA recycles the antioxidant network. ErgoX® provides stable mitochondrial-targeted defense. This is designed as a full lifecycle system: create, fuel, run, protect. Few formulations address all four stages.
Dual Neurotrophic Coverage
BioPQQ® stimulates NGF (nerve growth factor) for cholinergic neuron survival. CognatiQ® and Sabroxy® stimulate BDNF (brain-derived neurotrophic factor) for synaptic plasticity. Two growth factors, two neuronal populations, two complementary mechanisms — NGF for maintenance, BDNF for growth.
AM Biogenesis → PM Maintenance
APEX’s BioPQQ® drives mitochondrial creation during the day. RESET continues the mitochondrial program overnight: Ubiqsome® CoQ10 replenishes electron transport capacity, NeoAXT™ Astaxanthin protects membrane integrity, and Di-Mag Malate (550 mg in RESET) sustains Krebs cycle throughput during the repair-intensive sleep phase.
Key Takeaways
The Only Biogenesis Activator
BioPQQ® is among the few widely available supplements with clinical evidence for stimulating new mitochondrial creation via the PGC-1α → NRF-1 → TFAM cascade. It doesn’t just protect existing mitochondria — it supports the creation of new ones.
5,000x More Efficient Than Glutathione
PQQ cycles through ~20,000 redox reactions per molecule vs. ~4 for glutathione. This extraordinary catalytic efficiency provides sustained antioxidant defense at the mitochondrial electron transport chain.
Anti-Inflammatory in 72 Hours
Harris et al. (2013) showed BioPQQ® reduced C-reactive protein by ~45% within just 72 hours (open-label, n=10, no control group) — a notable anti-inflammatory signal, though from a very small uncontrolled study.
The Foundation of the Mitochondrial Stack
Inside APEX, BioPQQ® is the upstream driver that creates the mitochondria that ALCAR fuels, Di-Mag Malate energizes, Na-R-ALA protects, and ErgoX® shields. Without biogenesis, the rest of the stack optimizes a shrinking fleet.
Frequently Asked Questions
What is PQQ (pyrroloquinoline quinone)?
PQQ is a redox cofactor found naturally in soil, fermented foods (natto, fermented soybeans), and human breast milk. BioPQQ® is a patented, highly purified form produced via bacterial fermentation. PQQ is unique among widely available supplements in its demonstrated ability to activate PGC-1α, the master regulator of mitochondrial biogenesis.
How does PQQ create new mitochondria?
PQQ phosphorylates CREB, which upregulates PGC-1α — the transcription coactivator that controls mitochondrial creation. PGC-1α then activates NRF-1/NRF-2 transcription factors, which drive TFAM into the mitochondrial matrix to replicate mitochondrial DNA and build new electron transport chains. This is the same biogenesis cascade activated by exercise.
Why is BioPQQ® only 10 mg when studies use 20 mg?
The primary clinical trials used 20 mg/day. APEX delivers 10 mg within a comprehensive mitochondrial stack (ALCAR, Na-R-ALA, Di-Mag Malate, ErgoX®) that addresses complementary metabolic nodes. Cell studies show PQQ activates PGC-1α at nanomolar concentrations — the dose-response threshold is low. The synergistic context supports biological activity at 10 mg.
What makes PQQ different from other antioxidants?
PQQ cycles between oxidized and reduced forms approximately 20,000 times before degradation — compared to ~4 cycles for glutathione and ~800 for vitamin C. This makes PQQ roughly 5,000x more catalytically efficient per molecule. It also acts as both an antioxidant AND a biogenesis activator — most antioxidants only protect existing structures.
Does PQQ help with sleep?
Yes. Nakano et al. (2012) demonstrated that BioPQQ® at 20 mg/day significantly improved sleep duration, sleep onset, and reduced fatigue-on-waking in an 8-week crossover trial. The mechanism may relate to mitochondrial efficiency in sleep-regulating brain regions and PQQ’s anti-inflammatory action via NF-κB suppression.
How does BioPQQ® work with other ingredients in APEX?
BioPQQ® is the upstream driver of the mitochondrial lifecycle: it creates new mitochondria. ALCAR delivers fuel via the carnitine shuttle. Di-Mag Malate provides Krebs cycle substrate. Na-R-ALA recycles the antioxidant network. ErgoX® provides stable mitochondrial-targeted defense. Together they form a complete create-fuel-run-protect system.
References
- [1]Itoh, Y., Hine, K., Miura, H., Uetake, T., Nakano, M., Takemura, N., & Inui, A. (2016). Effect of the antioxidant supplement pyrroloquinoline quinone disodium salt (BioPQQ™) on cognitive functions. Functional Foods in Health and Disease, 876, 319–325.View
- [2]Nakano, M., Ubukata, K., Yamamoto, T., & Yamaguchi, H. (2012). Effect of pyrroloquinoline quinone (PQQ) on mental status of middle-aged and elderly persons. Functional Foods in Health and Disease, 2(8), 307–324.View
- [3]Harris, C. B., Chowanadisai, W., Mishchuk, D. O., Satre, M. A., Slupsky, C. M., & Rucker, R. B. (2013). Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects. Journal of Nutritional Biochemistry, 24(12), 2076–2084.View
Upgrade Your Mitochondrial Fleet
BioPQQ® is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.